Nanoparticle abraxane possesses impaired proliferation in A549 cells due to the underexpression of glucosamine 6-phosphate N-acetyltransferase 1 (GNPNAT1/GNA1)

Int J Nanomedicine. 2017 Mar 1:12:1685-1697. doi: 10.2147/IJN.S129976. eCollection 2017.

Abstract

Abraxane (Abr), a US Food and Drug Administration-approved albumin-bound nanoparticle applied for the treatment of non-small-cell lung cancer, has been reported to be more effective than paclitaxel (PTX). To further understand the molecular mechanisms that produce this superior drug efficacy of Abr, a quantitative proteomic approach has been applied to investigate the global protein expression profiles of lung cancer cell A549 treated with Abr and PTX. Only one protein, namely, glucosamine 6-phosphate N-acetyltransferase 1 (GNA1), showed significant differential expression (P<0.05) in the cutoff of 2.0 fold, suggesting that Abr can be used safely as a substitute for PTX. GNA1 is a key enzyme in the biosynthesis of uridine diphosphate-N-acetylglucosamine, which is an important donor substrate for N-linked glycosylation and has several important functions such as embryonic development and growth. Albumin plays a major role in the regulation of this protein. In summary, this study first shows that the superior drug effect of Abr is mainly due to the downregulation of GNA1, which causes proliferative delay and cell adhesion defect. It is also noteworthy that the deficiency of GNA1 might reduce insulin secretion which correlates with type 2 diabetes.

Keywords: abraxane; drug efficacy; lung cancer; molecular mechanisms; nano-drug; quantitative proteomics.

MeSH terms

  • A549 Cells
  • Actins / metabolism
  • Albumin-Bound Paclitaxel / pharmacology*
  • Apoptosis / drug effects
  • Blotting, Western
  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Cell Adhesion / drug effects
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Chromatography, Liquid
  • Glucosamine 6-Phosphate N-Acetyltransferase / metabolism*
  • Humans
  • Isotope Labeling
  • Lung Neoplasms / pathology*
  • Models, Biological
  • Nanoparticles / chemistry*
  • Paclitaxel / pharmacology
  • Polymerization
  • Proteomics
  • Reproducibility of Results
  • Tandem Mass Spectrometry

Substances

  • Actins
  • Albumin-Bound Paclitaxel
  • Glucosamine 6-Phosphate N-Acetyltransferase
  • Paclitaxel